Bacterial Infections

• EMA withdrawal · 2016-12-06
  EMA Application withdrawn: Ertapenem Hospira (ertapenem sodium) — Hospira UK Limited

  EMA has withdrawn the application for Ertapenem Hospira (ertapenem sodium) by Hospira UK Limited.

• CLINICAL_TRIALS withdrawal · 2015-04-22
  Clinical Trial Update: A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc. [Phase 1]

  This update notes the withdrawal of a Phase 1 study evaluating GSK945237 in healthy adults, including assessments of safety, pharmacokinetic…

• EMA withdrawal · 2010-01-11
  EMA Withdrawn: Turvel (trovafloxacin) — Pfizer Limited

  EMA has withdrawn Turvel (trovafloxacin) from the market for bacterial infections after a decision by Pfizer Limited.

• EMA withdrawal · 2009-12-31
  EMA Withdrawn: Trovan (trovafloxacin) — Pfizer Limited

  The European Medicines Agency has withdrawn Trovan (trovafloxacin) from the market; the decision affects its use for bacterial infections.

• EMA withdrawal · 2009-12-31
  EMA Withdrawn: Trovan IV (alatrofloxacin mesilate) — Pfizer Limited

  EU status: Trovan IV (alatrofloxacin mesilate) withdrawn from the market by Pfizer Limited as of 31/12/2009.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.